With India facing over 101 million cases of diabetes and rising obesity levels, the drug could play a significant role in ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting ...

Looking to expand its footprint in the booming glucagon-like peptide (GLP-1) market, Danish drugmaker Novo Nordisk has ...

Ozempic can be beneficial for a lot of people, however, some people should avoid it. Read on to know why the drug is not for ...

Ozempic one of the most sought-after drugs across the world for its Type 2 Diabetes and weight loss treatment will be available in India at a starting weekly dose of 025 mg priced at INR 2200 ...

While Ozempic offers proven benefits for blood sugar control, weight management, and cardiovascular protection, its arrival ...

Doctors typically begin patients on 0.25 mg once a week for the first month. After the introductory phase, the dosage ...

Ozempic, the global blockbuster diabetes and weight-loss drug, is finally in India. Novo Nordisk India launched the hugely ...

Novo Nordisk’s blockbuster diabetes drug, Ozempic, was officially launched in India on December 12. Unlike in the US and ...

Ozempic, a GLP-1 receptor agonist, has officially launched in India, offering a new treatment option for type 2 diabetes.

Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs ...

The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines ...